According to a recent LinkedIn post from Draig Therapeutics, CEO and President Ivana Magovcevic-Liebisch is scheduled to participate in an off-the-record C-suite session at the upcoming Convergence Forum. The session, set for Friday, May 8 from 10:15 to 11:15 a.m., will include senior leaders from Aitia, Xilio Therapeutics, Inc., and Atlas Venture.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests that Draig Therapeutics is positioning its leadership alongside prominent industry and investment figures to discuss key healthcare topics in a closed-door setting. For investors, this type of participation may signal efforts to strengthen strategic relationships, gain industry insights, and potentially access future partnering or financing opportunities, although no specific business outcomes are indicated in the post.